Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL9QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,473
Award facts
- Contract value 100% obligated
- $22,473.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,473.42 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count) on December 1, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The prime vendor agreement, designated SPE2DX and valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's performance under the DLA Medical Supply Chain demonstrates its capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000. This delivery order for Tagrisso, an oncology medication, exemplifies AmerisourceBergen's role as a key supplier in supporting military medical readiness and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FL9QB?
SPE2DR26FL9QB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FL9QB worth?
The government has obligated $22,473 on SPE2DR26FL9QB.
Is contract SPE2DR26FL9QB an order under another contract?
Yes. SPE2DR26FL9QB is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9QB competed?
The extent of competition for SPE2DR26FL9QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award